IndraLab

Statements

Bortezomib increases the amount of USP5. 1 / 2

1 | 1

reach

"The present study showed that distinct T-channel blockers or knockdown of Ca v 3.2 reversed BIPN in mice, and that bortezomib treatment increased protein levels of Ca v 3.2 and USP5, known to prevent [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

30552955

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Bortezomib increases the amount of USP5. 1 / 2

INDRA sources:

Databases

Reading